HUT70615A - Process for producing acetic acid derivatives and pharmaceutical compositions containing them - Google Patents

Process for producing acetic acid derivatives and pharmaceutical compositions containing them

Info

Publication number
HUT70615A
HUT70615A HU9400517A HU9400517A HUT70615A HU T70615 A HUT70615 A HU T70615A HU 9400517 A HU9400517 A HU 9400517A HU 9400517 A HU9400517 A HU 9400517A HU T70615 A HUT70615 A HU T70615A
Authority
HU
Hungary
Prior art keywords
acetic acid
pharmaceutical compositions
compositions containing
acid derivatives
producing acetic
Prior art date
Application number
HU9400517A
Other languages
English (en)
Other versions
HU213107B (en
HU9400517D0 (en
Inventor
Marton Fekete
Tibor Mezei
Zoltan Budai
Katalin Szemeredi
Istvan Gacsalyi
Jozsefne Reiter
Gabor Blasko
Andras Egyed
Istvan Gyertyan
E Szilveszter Vizi
Gyula Simig
Gaborne Takats
Original Assignee
Egyt Gyogyszervegyeszeti Gyar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Egyt Gyogyszervegyeszeti Gyar filed Critical Egyt Gyogyszervegyeszeti Gyar
Priority to HU9400517A priority Critical patent/HU213107B/hu
Publication of HU9400517D0 publication Critical patent/HU9400517D0/hu
Priority to KR1019960704569A priority patent/KR970701177A/ko
Priority to EP95909911A priority patent/EP0746549A1/en
Priority to AU29728/95A priority patent/AU2972895A/en
Priority to JP7522225A priority patent/JPH09512784A/ja
Priority to PCT/HU1995/000003 priority patent/WO1995023137A1/en
Publication of HUT70615A publication Critical patent/HUT70615A/hu
Publication of HU213107B publication Critical patent/HU213107B/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D219/00—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems
    • C07D219/04—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • C07D219/08—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D219/00—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems
    • C07D219/04—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • C07D219/08—Nitrogen atoms
    • C07D219/10—Nitrogen atoms attached in position 9
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Psychiatry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
HU9400517A 1994-02-23 1994-02-23 Process for producing acetic acid derivatives and pharmaceutical compositions containing them HU213107B (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
HU9400517A HU213107B (en) 1994-02-23 1994-02-23 Process for producing acetic acid derivatives and pharmaceutical compositions containing them
KR1019960704569A KR970701177A (ko) 1994-02-23 1995-02-22 아세트산 아미드 유도체 및 그것의 제조 방법(amide derivatives and process for the preparation thereof)
EP95909911A EP0746549A1 (en) 1994-02-23 1995-02-22 Acetic acid amide derivatives and process for the preparation thereof
AU29728/95A AU2972895A (en) 1994-02-23 1995-02-22 Acetic acid amide derivatives and process for the preparation thereof
JP7522225A JPH09512784A (ja) 1994-02-23 1995-02-22 酢酸アミド誘導体及びその製造方法
PCT/HU1995/000003 WO1995023137A1 (en) 1994-02-23 1995-02-22 Acetic acid amide derivatives and process for the preparation thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU9400517A HU213107B (en) 1994-02-23 1994-02-23 Process for producing acetic acid derivatives and pharmaceutical compositions containing them

Publications (3)

Publication Number Publication Date
HU9400517D0 HU9400517D0 (en) 1994-05-30
HUT70615A true HUT70615A (en) 1995-10-30
HU213107B HU213107B (en) 1997-02-28

Family

ID=10984860

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9400517A HU213107B (en) 1994-02-23 1994-02-23 Process for producing acetic acid derivatives and pharmaceutical compositions containing them

Country Status (6)

Country Link
EP (1) EP0746549A1 (hu)
JP (1) JPH09512784A (hu)
KR (1) KR970701177A (hu)
AU (1) AU2972895A (hu)
HU (1) HU213107B (hu)
WO (1) WO1995023137A1 (hu)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1415651A4 (en) * 2001-08-06 2005-11-09 Mitsubishi Pharma Corp PROPHYLACTIC / THERAPEUTIC COMPOSITIONS FOR CHOLINERGIC NEUROPATHY
JP4598674B2 (ja) * 2003-01-08 2010-12-15 田辺三菱製薬株式会社 統合失調症治療剤
US7378524B2 (en) 2003-04-11 2008-05-27 Taigen Biotechnology Co., Ltd. Aminoquinoline compounds
CA2521619A1 (en) 2003-04-11 2004-10-28 Taigen Biotechnology Aminoquinoline compounds
GB0316094D0 (en) 2003-07-09 2003-08-13 Neuropharma Sa Acetylcholinesterase dual inhibitors
KR101288781B1 (ko) 2006-06-28 2013-07-22 암젠 인크 글리신 수송자-1 억제제
CN105367553A (zh) * 2015-12-04 2016-03-02 广东工业大学 一种他克林-8-羟（胺）基喹啉衍生物及其应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0319429B1 (en) * 1987-12-03 1994-04-27 Mitsubishi Kasei Corporation 9-Acylamino-tetrahydroacridine derivatives and memory enhancing agent containing said derivative as active ingredient
US4999430A (en) * 1989-07-31 1991-03-12 Warner-Lambert Company Derivatives of 1,2,3,4-tetrahydro-9-acrisinamine
GB8917568D0 (en) * 1989-08-01 1989-09-13 Morton Oswald Compounds

Also Published As

Publication number Publication date
HU213107B (en) 1997-02-28
KR970701177A (ko) 1997-03-17
JPH09512784A (ja) 1997-12-22
AU2972895A (en) 1995-09-11
HU9400517D0 (en) 1994-05-30
WO1995023137A1 (en) 1995-08-31
EP0746549A1 (en) 1996-12-11

Similar Documents

Publication Publication Date Title
HUT63632A (en) Process for producing 5-amino-4-hydroxyhexanoic acid derivatives and pharmaceutical compositions comprising same
HUT70526A (en) Indole-2-carboxylic acid derivatives, process for producing thereof and pharmaceutical compositions comprising same compounds
HU9303521D0 (en) Process for producing carboxylic acid derivatives and pharmaceutical compositions containing them
HU9401411D0 (en) Bile acid derivatives, process for producing them and pharmaceutical compositions containing them
HUT56565A (en) Process for producing 3-arylcarbonyl-1h-indole derivatives and pharmaceutical compositions comprising same
HUT76286A (en) Quinoline derivatives, pharmaceutical compositions containing them, process for producing them and their use
HUP9600680A2 (en) Benzazepine,-benzoxazepine- and benzothiazepine-n-acetic acid derivatives, process for producing them, and pharmaceutical compositions containing them
HU9400413D0 (en) Imidazoly-alcenoic acids, pharmaceutical compositions containing them, and process for producing them
ZA969248B (en) New aminoacid derivatives process for the manufacture thereof and pharmaceutical compositions containing thesse compounds
HUT52093A (en) Process for producing indazole-3-carboxylic acid derivatives and pharmaceutical compositions comprising same
HUT63628A (en) Process for producing new cefalosporing derivatives and pharmaceutical compositions comprising same
IL115072A (en) Pharmaceutical compositions containing substituted 4-phenyl-6-amino-nicotinic acid derivatives their preparation some such new compounds and process for their preparation
HUT54112A (en) Process for producing benzocycloalkane derivatives and pharmaceutical compositions comprising same
HUT64059A (en) Process for producing benzimidazole derivatives and pharmaceutical compositions comprising same
HU9501041D0 (en) Peptide-boronic acid derivatives, process for producing them and pharmaceutical application thereof
IL116560A0 (en) Substituted 2-amino-4-phenylthiazole derivatives process for their preparation and pharmaceutical compositions containing them
HUT70615A (en) Process for producing acetic acid derivatives and pharmaceutical compositions containing them
ZA966154B (en) Aminophenylphosphonic acid compounds process for preparing them and pharmaceutical compositions containing them
HU9400325D0 (en) Process for producing amino-ascorbic acid derivatives and pharmaceutical compositions containing them
HUT55755A (en) Process for producing indole derivatives and pharmaceutical compositions comprising same
GB9409395D0 (en) Sialic acid derivatives and process for their preparation
HUT54165A (en) Process for producing cefalosporin derivatives and pharmaceutical compositions comprising same
HUT49615A (en) Process for producing cefemkarboxylic acid derivatives and pharmaceutical compositions comprising same
EG20289A (en) Process for preparing of novel pharmaceutical compositions comprising 3- substituted 2-oxindole -1- corboximides
HUT63629A (en) Process for producing substituted phenylquinazoline derivatives and pharmaceutical compositions comprising same

Legal Events

Date Code Title Description
HC9A Change of name, address

Owner name: EGIS GYOGYSZERGYAR NYRT., HU

Free format text: FORMER OWNER(S): EGIS GYOGYSZERGYAR RT., HU

MM4A Lapse of definitive patent protection due to non-payment of fees